Cimpress
CMPR
73.59
-0.06
-0.08%
Cimpress
US · CMPR
#2851 by market cap
Listed 1970
73.59
-0.06
-0.08%
Live - 5344 symbols - heartbeat 468s ago
· 2026-10-08 06:42
Pre-market
73.94
+0.48%
After-hours
73.55
-0.05%
- Market cap
- 1.79B
- P/E (TTM)i
- 19.42
- P/Bi
- -3.63
- EPSi
- 3.79
- Div yieldi
- 0.00%
- 52W posi
- 28%
Reader sentiment
Are you bullish or bearish on CMPR?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.56, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.80% YoY
Margins
- Gross margin
- 46.29%
- Operating margin
- 6.89%
- Net margin
- 2.57%
Key ratios & quality
- Enterprise valuei
- 3.19B
- Altman Z-Scorei
- 2.56
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.75B | 2.48B | 2.58B | 2.89B | 3.08B | 3.29B | 3.40B | 3.74B |
| Gross profit | 1.35B | 1.23B | 1.28B | 1.39B | 1.44B | 1.60B | 1.62B | 1.73B |
| Selling & admin expenses | 876.52M | 757.10M | 844.04M | 986.59M | 983.22M | 995.61M | 1.03B | 1.11B |
| Research & development | 236.80M | 253.25M | 253.06M | 292.85M | 302.26M | 321.97M | 334.04M | 352.54M |
| Operating profit | 183.16M | 170.35M | 125.15M | 60.90M | 106.68M | 247.77M | 231.80M | 257.29M |
| Pretax profit | 126.91M | 3.00M | -63.55M | 9.33M | -30.22M | 128.45M | 96.96M | 152.89M |
| Tax | 33.43M | -80.99M | 18.90M | 59.90M | 155.49M | -49.36M | 84.11M | 55.78M |
| Net profit | 93.48M | 84.00M | -82.46M | -50.57M | -185.72M | 177.81M | 12.85M | 97.11M |
| Basic EPS | 3 | 3 | -3 | -2 | -7 | 7 | 1 | 4 |
| Diluted EPS | 3.00 | 3.00 | -3.28 | -2.08 | -7.08 | 6.43 | 0.58 | 3.79 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 789.47M | 869.48M | 863.28M | 1.04B | 886.21M | 944.96M |
| Gross profit | 372.51M | 412.80M | 402.80M | 487.72M | 409.20M | 429.99M |
| Selling & admin expenses | 243.87M | 252.11M | 264.39M | 306.36M | 267.44M | 267.90M |
| Research & development | 83.11M | 86.18M | 84.89M | 89.08M | 86.89M | 91.68M |
| Operating profit | 41.01M | 70.24M | 49.27M | 89.40M | 51.98M | 66.63M |
| Pretax profit | 4.12M | 13.46M | 24.36M | 62.83M | 26.35M | 39.36M |
| Tax | 12.14M | 41.82M | 17.84M | 13.34M | 11.71M | 12.89M |
| Net profit | -8.02M | -28.36M | 6.52M | 49.49M | 14.64M | 26.46M |
| Basic EPS | 0 | -1 | 0 | 2 | 1 | 1 |
| Diluted EPS | -0.33 | -1.01 | 0.30 | 1.95 | 0.55 | 0.97 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 240.30M | 248.40M | 528.50M | 626.32M | 441.03M | 457.98M | 502.61M | 564.45M |
| Cash & ST investments | 35.28M | 45.02M | 335.27M | 327.01M | 168.85M | 208.28M | 233.98M | 248.85M |
| Inventory | 66.31M | 80.18M | 70.04M | 126.73M | 107.84M | 97.02M | 112.87M | 136.98M |
| Total assets | 1.87B | 1.82B | 2.18B | 2.17B | 1.85B | 1.89B | 1.97B | 2.20B |
| Total current liabilities | 520.75M | 486.76M | 638.17M | 692.54M | 645.33M | 663.96M | 758.66M | 775.59M |
| Short-term debt | 104.51M | 67.76M | 68.76M | 44.78M | 43.21M | 40.45M | 40.27M | 51.70M |
| Long-term debt | 942.29M | 1.42B | 1.73B | 1.68B | 1.63B | 1.59B | 1.58B | 1.60B |
| Total liabilities | 1,673,382,000.00 | 2,153,376,000.00 | 2,560,749,000.00 | 2,531,111,000.00 | 2,466,652,000.00 | 2,418,671,000.00 | 2,531,590,000.00 | 2,600,788,000.00 |
| Total equity | 194.99M | -338.37M | -378.25M | -363.44M | -611.79M | -526.51M | -563.45M | -398.28M |
| Retained earnings | 537.42M | 618.44M | 530.16M | 414.14M | 235.40M | 272.88M | 225.12M | 279.42M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 443.71M | 502.61M | 489.27M | 561.15M | 495.81M | 564.45M |
| Cash & ST investments | 183.00M | 233.98M | 200.51M | 258.04M | 189.00M | 248.85M |
| Inventory | 101.90M | 112.87M | 119.47M | 122.75M | 123.81M | 136.98M |
| Total assets | 1.88B | 1.97B | 1.97B | 2.09B | 2.05B | 2.20B |
| Total current liabilities | 679.70M | 758.66M | 754.64M | 826.07M | 730.00M | 775.59M |
| Short-term debt | 37.89M | 40.27M | 40.04M | 48.02M | 49.06M | 51.70M |
| Long-term debt | 1.58B | 1.58B | 1.57B | 1.58B | 1.58B | 1.60B |
| Total liabilities | 2,415,023,000.00 | 2,531,590,000.00 | 2,518,866,000.00 | 2,618,338,000.00 | 2,508,803,000.00 | 2,600,788,000.00 |
| Total equity | -536.71M | -563.45M | -552.33M | -523.97M | -453.90M | -398.28M |
| Retained earnings | 266.18M | 225.12M | 230.70M | 260.94M | 256.45M | 279.42M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 331.10M | 338.44M | 265.22M | 219.54M | 130.29M | 350.72M | 298.07M | 283.71M |
| Depreciation & amortization | 173.77M | 167.94M | 173.21M | 175.68M | 162.43M | 151.76M | 141.13M | 151.84M |
| Free cash flow | 211.88M | 243.99M | 165.76M | 100.20M | 18.73M | 237.49M | 144.95M | 116.42M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -52.16M | -627.05M | -- | 0 | 327.00K | -154.88M | -76.40M | -47.37M |
| Ending cash balance | 35.28M | 45.02M | 183.02M | 277.05M | 130.31M | 203.78M | 233.98M | 248.85M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 9.70M | 107.47M | 25.06M | 164.66M | -16.52M | 110.51M |
| Depreciation & amortization | 34.30M | 36.07M | 36.62M | 36.62M | 37.41M | 41.20M |
| Free cash flow | -31.44M | 70.16M | -18.58M | 123.46M | -56.32M | 67.86M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -3.94M | -20.84M | -2.22M | -24.68M | -21.69M | 1.23M |
| Ending cash balance | 183.00M | 233.98M | 200.51M | 258.04M | 189.00M | 248.85M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 84.31 | -- | -- | -- | -- | -- | -- | -- |
| ROA %i | 5.40 | 4.53 | -3.89 | -2.50 | -9.25 | 9.27 | 0.77 | 4.60 |
| ROIC %i | 11.95 | -- | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | 28.22 | -- | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.91 | 3.18 | 2.44 | 3.77 | 2.68 | 7.54 | 6.24 | 6.92 |
| FCF / sales %i | 7.70 | 9.83 | 6.39 | 3.47 | 0.61 | 7.21 | 4.26 | 3.12 |
| Current ratioi | 0.46 | 0.51 | 0.83 | 0.90 | 0.68 | 0.69 | 0.66 | 0.73 |
| Quick ratioi | 0.18 | 0.16 | 0.60 | 0.56 | 0.37 | 0.41 | 0.40 | 0.42 |
| Debt / assetsi | 62.89 | 89.86 | 86.42 | 82.69 | 94.72 | 91.02 | 86.74 | 81.20 |
| LT debt / equityi | 812.08 | -- | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 3.01 | 1.04 | 0.53 | 1.09 | 0.73 | 2.07 | 1.84 | 2.45 |
| Revenue CAGR (3Y) %i | 15.44 | 5.13 | -0.21 | 1.63 | 7.47 | 8.52 | 5.63 | 6.66 |
| Net income CAGR (3Y) %i | 20.48 | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | 14.78 | 75.58 | 22.47 | -22.09 | -57.50 | 12.73 | 13.10 | 83.86 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- | -- |
| ROA %i | 8.48 | 0.77 | 1.83 | 1.17 | 2.31 | 4.60 |
| ROIC %i | -- | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 6.96 | 6.24 | 6.84 | 6.02 | 6.42 | 6.92 |
| FCF / sales %i | 5.18 | 4.26 | 4.44 | 4.03 | 3.24 | 3.12 |
| Current ratioi | 0.65 | 0.66 | 0.65 | 0.68 | 0.68 | 0.73 |
| Quick ratioi | 0.37 | 0.40 | 0.37 | 0.40 | 0.36 | 0.42 |
| Debt / assetsi | 90.59 | 86.74 | 86.94 | 83.58 | 84.96 | 81.20 |
| LT debt / equityi | -- | -- | -- | -- | -- | -- |
| Interest coveragei | 1.99 | 1.84 | 2.11 | 1.95 | 2.17 | 2.45 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Vista is the largest reported line at 51.77% of revenue, across 6 reported segments.
- PrintBrothers follows at 22.03%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Vista51.77%
PrintBrothers22.03%
National Pen11.96%
The Print Group11.93%
All Other Businesses6.91%
Region
Other41.55%
United States41.35%
Germany17.10%
Quote time 2026-10-08 06:42:30 · For reference only, not investment advice and not tailored to your situation.